Robert Coury - 2009 CEO Pay

Robert Coury, Mylan CEO

Robert Coury - Mylan

Total Compensation: $16.5 million

Details: In 2009, Robert Coury saw his compensation increase dramatically over the previous year. Coury took in just under $16.5 million compared with about $13.2 million in 2008. In addition, his salary increased more than $66,000 to about $1.6 million. He also received stock awards worth $3 million and option awards of about $2.4 million

Mylan News:
Mylan chief's pay tops $16M; Cephalon's drops to $11M
Mylan execs' pay leaps by 41%
Mylan CEO makes $10M in 9 months

Robert Coury - 2009 CEO Pay
Read more on

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.